Subjective well-being among clinically stable psychiatric outpatients: differences between mood disorders, subthreshold conditions, and community controls - Top-Institutions - MDSpire

Subjective well-being among clinically stable psychiatric outpatients: differences between mood disorders, subthreshold conditions, and community controls

  • By

  • Mihoko Kawai

  • Hiroko Goji

  • Takahide Fukatsu

  • Jun Miyata

  • Kousuke Kanemoto

  • February 27, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Psychiatry
    • Clinical Psychology
    • Psychiatric Research

  • #2

    University of California, San Francisco (UCSF) Medical Center
    University of California, San Francisco (UCSF) Medical Center

    San Francisco, CA

    Key Differentiators

    • Psychiatry
    • Behavioral Sciences
    • Mental Health Services Research

  • #3

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Psychiatry
    • Neuroscience
    • Public Mental Health

  • #4

    University of Pennsylvania Perelman School of Medicine
    University of Pennsylvania Perelman School of Medicine

    Philadelphia, PA

    Key Differentiators

    • Psychiatry
    • Clinical Neuroscience
    • Behavioral Health

  • #5

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, NY

    Key Differentiators

    • Psychiatry
    • Psychiatric Epidemiology
    • Mental Health Services

Original Source(s)

Subjective well-being among clinically stable psychiatric outpatients: differences between mood disorders, subthreshold conditions, and community controls

  • by Mihoko Kawai, Hiroko Goji, Takahide Fukatsu, Jun Miyata, Kousuke Kanemoto

  • February 27, 2026

Related Content

Positive Mental Health Screens in the Veterans Health Administration, 2021 to 2024

The dual-sensitive period gut-brain crosstalk, neuroinflammation, and the biological roots of adolescent depression

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.